Evidence map›Paper›PMID 42767398›Full record

ArticleNeuroscience letters2026

Prior trauma shapes the effects of psilocybin on stress sensitization in mice.

Sophia R Ottofaro, Jessica L Maltman, Javier González-Maeso

Abstract read
In one paragraph

Article in Neuroscience letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sophia R OttofaroDepartment of Pharmacology and Toxicology, Virginia Commonwealth University School of Medicine, Richmond, VA 23298, USA.
Jessica L MaltmanDepartment of Pharmacology and Toxicology, Virginia Commonwealth University School of Medicine, Richmond, VA 23298, USA; Biomedical Sciences Graduate Program, Virginia Commonwealth University School of Medicine, Richmond, VA 23298, USA.
Javier González-MaesoDepartment of Pharmacology and Toxicology, Virginia Commonwealth University School of Medicine, Richmond, VA 23298, USA. Electronic address: javier.maeso@vcuhealth.org.

Funding

TRAINING IN THE PHARMACOLOGY OF ABUSED DRUGST32DA007027 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI William L. Dewey · 1985 to 2026
$14.7M
Structure and function of the 5HT2A/mGluR2 complex in schizophreniaR01MH084894 · NIMH · VIRGINIA COMMONWEALTH UNIVERSITY · PI Javier Gonzalez-Maeso · 2009 to 2026
$6.8M
NIDA NIH HHS T32 DA007027NIMH NIH HHS R01 MH084894
6 · The paper itself

Abstract

Exposure to traumatic events induces persistent alterations in defensive behavior that extend beyond associative fear memories, including heightened responses to novel stimuli (stress sensitivity) and sustained defensive states in neutral contexts (stress sensitization). While serotonergic psychedelics such as psilocybin have been shown to facilitate fear extinction in associative paradigms, their effects on trauma-induced non-associative stress adaptations remain poorly understood. Here, we developed a behavioral paradigm in mice that dissociates contextual fear recall from stress sensitivity and stress sensitization within the same subjects. Male C57BL/6J mice were exposed to an acute foot-shock stressor, followed by assessment of trauma recall, administration of psilocybin (1 mg/kg) or vehicle, and subsequent evaluation of responses to a novel auditory stimulus and context. Trauma-exposed mice displayed robust associative fear and increased freezing in response to a novel auditory stimulus, consistent with enhanced stress sensitivity. However, psilocybin did not significantly alter this stimulus-evoked response. In contrast, psilocybin produced bidirectional, experience-dependent effects on stress sensitization - it reduced baseline freezing in non-traumatized mice but increased freezing in trauma-exposed animals when re-exposed to a novel context in the absence of a stimulus. Together, these findings demonstrate that psilocybin does not uniformly attenuate trauma-related behaviors, but instead modulates non-associative defensive responses in a manner dependent on prior experience. This work highlights the importance of distinguishing between associative and non-associative components of fear and suggests that psychedelic-induced plasticity may amplify latent trauma-related states under certain conditions.

Indexed as

Classical hallucinogensDefensive behaviorFear conditioningPost-traumatic stress disorder (PTSD) modelsPsilocybinPsychedelicsStress sensitivityStress sensitizationTrauma

Identifiers

PMID42767398
PMCPMC13639587

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.